Statements of Operations - USD ($)	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024
Operating expenses:
Research and development	$ 25,215,607	$ 19,995,447
General and administrative	4,479,651	6,699,481
Total operating expenses	29,695,258	26,694,928
Operating loss	(29,695,258)	(26,694,928)
Other income (expense):
Interest income	699,061	331,849
Other financing costs		(1,853,189)
Change in fair value of warrants	142,000	3,625,893
Total other income, net	841,061	2,104,553
Net loss	$ (28,854,197)	$ (24,590,375)
Net loss per share
Basic (dollars per share)	$ (1.4)	$ (2.02)
Diluted (dollars per share)	$ (1.4)	$ (2.31)
Weighted-average number of common shares used in computing net loss per share
Basic	20,551,997	12,182,475
Diluted	20,551,997	12,235,444